Finance

Lists
Why is BGLC down 2,78%?
Dive Deeper
BGLC:NASDAQ
BioNexus Gene Lab Corp
1,21 USD
-2,78%
(-0,035) 1D
7-окт., 13:03:54 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BGLC...
Open
1,33 USD
High
1,33 USD
Low
1,21 USD
Mkt. cap
3,54 млн
Avg. vol.
7,19 миң
Volume
12,96 миң
52-wk high
5,85 USD
52-wk low
1,07 USD
EPS
-1,25 USD
Beta
-0,94
Shares outstanding
2,93 млн
No. of employees
19
Open
1,33 USD
High
1,33 USD
Low
1,21 USD
Mkt. cap
3,54 млн
Avg. vol.
7,19 миң
Volume
12,96 миң
52-wk high
5,85 USD
52-wk low
1,07 USD
EPS
-1,25 USD
Beta
-0,94
Shares outstanding
2,93 млн
No. of employees
19
News stories
From web sources and news partners
About BioNexus Gene Lab Corp
CEO-
Employees19
Founded2017
Headquarters-
SectorTrading company
Websitebionexusgenelab.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
2,54 млн
483,76 миң
22,84 миң
76,16 миң
Cost of goods sold
2,17 млн
487,74 миң
23,63 миң
63,17 миң
Cost of revenue
2,17 млн
487,74 миң
23,63 миң
63,17 миң
Research and development expenses
14,88 миң
11,10 миң
14,49 миң
13,67 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
997,26 миң
216,74 миң
380,40 миң
334,55 миң
Operating expense
1,15 млн
1,12 млн
562,50 миң
316,61 миң
Total operating expenses
3,31 млн
1,60 млн
586,13 миң
379,78 миң
Operating income
-769,86 миң
-1,12 млн
-563,29 миң
-303,62 миң
Other non operating income
-
1,40 миң
-
-
EBT including unusual items
-708,99 миң
-1,04 млн
-543,58 миң
-286,45 миң
EBT excluding unusual items
-751,37 миң
-1,21 млн
-543,58 миң
-286,45 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-40,41 миң
87,75 миң
-8,15 миң
-8,39 миң
Net income
-708,99 миң
-1,04 млн
-543,58 миң
-286,45 миң
Net profit margin
-27,87%
-214,18%
-2 379,72%
-376,14%
Earnings per share
-
-
-
-
Interest and investment income
24,97 миң
10,13 миң
17,18 миң
21,18 миң
Interest expense
-6,48 миң
-3,27 миң
-3,08 миң
-4,06 миң
Net interest expenses
18,49 миң
6,86 миң
14,09 миң
17,13 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-740,85 миң
-1,09 млн
-534,99 миң
-272,84 миң
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору